CDC Logo Skip Top Nav
 CDC Home PageSearch the CDCHealth Topics A though Z
Division of Tuberculosis Elimination
About DTBE Upcoming Events Site Map CDC en Espanol Contact Us
Skip the Contents menu


Skip the Resources menu


U.S. Department of Health and Human Services

TB-Related Articles

Return to TB-Related Articles Table of Contents

Journal Articles Published by Division of TB Elimination (DTBE) Authors

January - December 2004

Cardoso RF, Cooksey RC, Morlock GP, Barco P, Cecon L, Forestiero F, Leite CQ, Sato DN, de Lourdes Shikama M, Mamizuka EM, Hirata RDC, and Hirata MH. Screening and characterization of mutations in isoniazid- resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob Agents Chemother 2004; 48:3373-3381.

Cegielski JP and McMurray DN. The relationship between malnutrition and tuberculosis: evidence from studies in humans and experimental animals. Int J Tuberc Lung Dis 2004 Mar;8(3):286-98.

Coffey CC, Lawrence RB, Campbell DL, Zhuang Z, Calvert CA, Jensen PA. Fitting characteristics of eighteen N95 filtering-facepiece respirators. Journal of Occupational and Environmental Hygiene 2004; 1: 262-271.

Cooksey RC, de Waard JH, Yakrus MA, Rivera I, Chopite M, Toney SR, Morlock GP, and Butler WR. Mycobacterium cosmeticum sp. nov., a novel rapidly growing species isolated from a cosmetic infection and from a nail salon. Int J Syst Evol Microbiol 2004; 54: 2385-2391.

Cowan LS, Diem L, Brake MC, and Crawford JT. Transfer of a Mycobacterium tuberculosis genotyping method, spoligotyping, from a reverse line-blot hybridization, membrane-based assay to the Luminex multianalyte profiling system. J Clin Microbiol 2004; 42:474-477.

Ferguson DD, Gershman G, Jensen B, Arduino MJ, Yakrus MA, Cooksey RC, and Srinivasan A. Mycobacterium goodii infections associated with surgical implants at Colorado hospital. Emerg. Infect Dis 2004; 10 (10): 1868-1871.

Iademarco M. Evaluation and epidemiological research in tuberculosis control: linking medical care and public health. Mayo Clinic Proceedings 2004; 79(9): 1110-1112. Editorial.

Ijaz K, Yang Z, Templeton G, Stead WW, Bates JH, Cave MD. Persistence of a strain of Mycobacterium tuberculosis in a prison system. Int J Tuberc Lung Dis 2004; 8(8): 994-1000.

Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ, Metchock B, Khan A, Burman WJ. Recurrent tuberculosis in the United States and Canada: relapse or reinfection? American Journal of Respiratory and Critical Care Medicine 2004 Dec 15; 170 (12): 1360-6.

Jasmer RM, Seaman CB, Gonzalez LC, Kawamura LM, Osmond DH, Daley CL. Tuberculosis treatment outcomes: directly observed therapy compared with self-administered therapy. American Journal of Respiratory and Critical Care Medicine 2004 Sep 1; 170 (5): 561-6.

Jereb J, Albalak R, Castro K. The Arden House Conference on Tuberculosis, revisited: perspectives for tuberculosis elimination in the United States. Seminars in Respiratory and Critical Care Medicine 2004; 25(3): 255-269.

Joseph JA, Shrestha-Kuwahara R, Lowry D, Lambert LA, Panlilio AL, Raucher BG, Holcome JM, Poujade J, Rasmussen DM, Wilce M. Factors influencing health care workers’ adherence to work site tuberculosis screening and treatment policies. Am J Infect Control 2004 Dec; 32(8):456-61.

Kline S, Cameron S, Streifel A, Yakrus MA, Kairis F, Peacock K, Besser J and Cooksey RC. An outbreak of bacteremias associated with Mycobacterium mucogenicum in a hospital water supply. Infect Control Hosp Epidemiol 2004; 25: 1042-1049.

Knackmuhs G, Gerwel M, Patterson C, Cipollone N, Navitski M, Lawler R, Monaco A, Dillon M, Bresnitz E, Tan C, Cooksey R, and Robertson CA. Mycobacterium chelonae infections associated with face lifts --- New Jersey, 2002-2003. MMWR 2004; 53:192-194.

Lobato M, Roberts C, Bazerman L, Hammett T. Public health and correctional collaboration in tuberculosis control. Am J Prev Med 2004; 27(2): 112-117.

LoBue PA, Betancourt W, Cowan L, Seli L, Peter C, Moser KS. Identification of a familial cluster of pulmonary Mycobacterium bovis disease. Int J Tuberc Lung Dis 2004 Sep; 8(9):1142-6.

LoBue PA, LeClair JJ, and Moser KS. Contact investigation for cases of pulmonary Mycobacterium bovis. Int J Tuberculosis Lung Dis 2004; 8: 868-872.

LoBue PA and Moser KS. Screening of immigrants and refugees for pulmonary tuberculosis in San Diego County, California. Chest 2004; 126: 1777-1782.

McNabb S, Kammerer S, Hickey A, Braden C, Shang N, Rosenblum L, Navin T. Added epidemiologic value to tuberculosis prevention and control of the investigation of clustered genotypes of Mycobacterium tuberculosis isolates. Am J Epidemiol 2004; 160(6): 589-597.

McNabb S, Surdo A, Redmond A, Cobb J, Wiley J, Chakrabarti S, Duncan H, Qualls N, Moore M. Applying a new conceptual framework to evaluate tuberculosis surveillance and action performance and measure the costs, Hillsborough County, Florida, 2002. AEP 2004; 14(9): 640-645.

Malone JS, Ijaz K, Lambert L, Rosencrans L, Phillips L, Tomlinson V, Arbise M, Moolenaar RL, Dworkin MS, Simoes EJ. Investigation of healthcare-associated transmission of Mycobacterium tuberculosis among patients with malignancies at three hospitals and at a residential facility. Cancer 2004 15 Dec;101(12): 2713-2721.

Marais BJ, Gie RP, Schaaf HS, Hesseling AC, Obihara CC, Nelson LJ, Enarson DA, Donald PR, Beyers N. The clinical epidemiology of childhood pulmonary tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004 Mar;8(3):278-85.

Mohamed AM, Bastola DR, Morlock GP, Cooksey RC, and Hinrichs SH. Temperature-mediated heteroduplex analyses for detection of pncA mutations associated with pyrazinamide resistance and differentiation between Mycobacterium tuberculosis and Mycobacterium bovis by denaturing high-performance liquid chromatography. J Clin Microbiol 2004; 42:1016-1023.

Nelson LJ and Wells CD. Tuberculosis in children: considerations for children from developing countries. Seminars in Pediatric Infectious Diseases 2004 Jul; 15(3):150-154.

Nelson LJ, Schneider E, Wells CD, Moore M. Epidemiology of childhood tuberculosis in the United States, 1993-2001: the need for continued vigilance. Pediatrics 2004; 114(2): 333-341.

Nelson LJ, Jereb JA, Castro KG. New guidelines about latent tuberculosis infection in children and adolescents: a welcome advancement. Pediatrics 2004 Oct;114(4):1084-6.

Nelson LJ and Wells CD. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 2004 May;8(5):636-47.

Nuermberger EL, Yoshimatsu T, Tyagi S, O'Brien RJ, Vernon AA, Chaisson RE, Bishai WR, Grosset JH. Moxifloxacin-containing regimen greatly reduces time to culture conversion in murine tuberculosis. Am J Respir Crit Care Med 2004;169:421-6.

Nuermberger EL, Yoshimatsu T, Tyagi S, Williams K, Rosenthal I, O’Brien RJ, Vernon AA, Chaisson RE, Bishai WR, and Grosset JH. Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosis. Am J Resp Crit Care Med 2004; 170:1131.

Pediatric Tuberculosis Collaborative Group (DTBE authors: Jereb J, Oxtoby M, Munsiff S, and Lobato M). Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents. Pediatrics 2004; 114: 1175-1201.

Rajbhandary SS, Marks SM, Bock NN. Costs of patients hospitalized for multidrug-resistant tuberculosis. Int J Tuberc Lung Dis 2004; 8(8): 1012-1016.

Schneider E, Laserson KF, Wells CD, Moore M. Tuberculosis along the United States-Mexico Border 1993-2001. Rev Panam Salud Publica/Pan Am J Public Health 2004; 16(1): 23-34.

Shemyakin IG, Stepanshina VN, Ivanov IY, Lipin MY, Anisimova VA, Onasenko AG, Korobova OV, and Shinnick TM. Characterization of drug-resistant clinical isolates of Mycobacterium tuberculosis derived from Russian inmates. Int J Tuberc Lung Dis 2004; 8, 1194-203.

Stanford MR, Whittall T, Bergmeier LA. Lindblad M, Lundin S, Shinnick T, Mizushima Y, Holmgren J, and Lehner T. Oral tolerization with peptide 336-351 linked to cholera toxin B subunit in preventing relapses of uveitis in Behcet's disease. Clin Exp Immunol 2004; 137, 201-8.

Talbot EA, Halabi S, Manchanda R, Mwansa RA, Wells CD. Knowledge, attitudes, and beliefs about directly-administered antiretroviral therapy among tuberculosis patients, Botswana 2002. Int J STD AIDS 2004; 15 (4): 282-3.

Talbot EA, Hay Burgess DC, Hone NM, Iademarco MF, Mwasekaga MJ, Moffat HJ, Moeti TL, Mwansa RA, Letsatsi P, Gokhale NT, Kenyon TA, and Wells CD. Tuberculosis serodiagnosis in a predominantly HIV-infected population of hospitalized patients with cough, Botswana, 2002. Clin Infect Dis 2004 Jul 1; 39(1): e1-e7 (electronic article).

Vernon AA and Iademarco M. In the treatment of tuberculosis, you get what you pay for…. Amer J Resp Crit Care Med 2004; 170:1040.

Weiner M, Bock N, Peloquin CA, Burman WJ, Khan A, Vernon A, Zhao Z, Weis S, Sterling TR, Hayden K, Goldberg S, and the Tuberculosis Trials Consortium. Pharmacokinetics of rifapentine at 600, 900, and 1200 mg during once-weekly tuberculosis therapy. Am J Respir Crit Care Med 2004; 169: 1191-1197.

Wells CD and Nelson LJ. New international efforts in childhood tuberculosis: proceedings from the 2002 Workshop on Childhood Tuberculosis, Montreal, Canada, 6-7 October 2002. Int J Tuberc Lung Dis 2004 May;8(5):630-5.

Winthrop K, Kubak B, Pegues D, Hufana C, Costamagna P, Desmond E, Sanders C, Shen P, Flores-Ibarra L, Osborne E, Bruckner D, Flood J. Transmission of Mycobacterium tuberculosis via lung transplantation. American Journal of Transplantation 2004; 1-5.

Winthrop KL, Albridge K, South D, Albrecht P, Abrams M, Samuel MC, Leonard W, Wagner J, Vugia DJ. The clinical management and outcome of nail salon–acquired Mycobacterium fortuitum skin infection. CID 2004 1 Jan; 38-44.

Yokoe DS, Coon SW, Dokholyan R, Iannuzzi MC, Jones TF, Meredith S, Moore M, Phillips L, Ray W, Schech S, Shatin D, Platt R. Pharmacy data for tuberculosis surveillance and assessment of patient management. Emerg Infect Dis 2004;10:1426-1431.


Last Reviewed: 05/18/2008
Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention


Back to Top of Page

If you would like to order any of the DTBE publications please visit the online order form.

You will need Adobe Acrobat™ Reader v5.0 or higher to read pages that are in PDF format.  Download the Adobe Acrobat™ Reader.

If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us in writing or via telephone and we will work with you to make the information available.

Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348

Skip Bottom Nav Home | Site Map | Contact Us
Accessibility | Privacy Policy Notice | FOIA |
CDC Home | Search | Health Topics A-Z

Centers for Disease Control & Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: